{"title": "Lorcaserina: una nueva alternativa para el tratamiento de la obesidad", "author": "Sobre el Autor", "url": "https://medicinainterna.org.mx/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/", "hostname": "medicinainterna.org.mx", "description": null, "sitename": "medicinainterna.org.mx", "date": "2019-03-22", "id": null, "license": null, "body": null, "comments": "Sin comentarios", "commentsbody": null, "raw_text": null, "text": "Lorcaserina: una nueva alternativa para el tratamiento de la obesidad\n[](https://medicinainterna.org.mx/descarga/11360/?tmstv=1678261130)\nLorcaserin: a new alternative for the treatment of obesity.\nMed Int M\u00e9x 2022; 38 (1): 121-129.\n[https://doi.org/10.24245/mim.v38i1.3733](https://doi.org/10.24245/mim.v38i1.3733)\nJorge Yamamoto-Cuevas,1 Paloma Almeda-Vald\u00e9s,2 Guadalupe Castro-Mart\u00ednez,3 Manuel Duarte-Vega,4 Gerardo Gonz\u00e1lez-Gir\u00f3n,5 Fernando Javier Lavalle-Gonz\u00e1lez,6 Hugo Antonio Laviada-Molina,7 Jos\u00e9 Agust\u00edn Mesa-P\u00e9rez,8 Roopa Pravin-Mehta,9 J H\u00e9ctor S\u00e1nchez-Mijangos,10 Rafael Margarito Violante-Ortiz,11 Sergio Z\u00fa\u00f1iga-Guajardo,12 Joan Erick G\u00f3mez-Miranda,13 Jorge Antonio Aldrete-Velasco,14 Benjam\u00edn Camacho-Silva,15 Orlando Mondrag\u00f3n-Ben\u00edtez15\n1 Endocrin\u00f3logo. Departamento de endocrinolog\u00eda del Hospital San \u00c1ngel Inn Universidad, Ciudad de M\u00e9xico.\n2 Endocrin\u00f3loga. M\u00e9dico adscrito al departamento de Endocrinolog\u00eda y Metabolismo, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n, Ciudad de M\u00e9xico.\n3 Internista. Directora de la Facultad Mexicana de Medicina, Universidad La Salle M\u00e9xico, Ciudad de M\u00e9xico.\n4 Internista. Divisi\u00f3n de Medicina Interna del Hospital Civil Juan I Menchaca, Universidad de Guadalajara, Jalisco, M\u00e9xico.\n5 Endocrin\u00f3logo. Hospital General Regional de Especialidades Vicente Guerrero, IMSS, Acapulco, Guerrero, M\u00e9xico.\n6 Endocrin\u00f3logo. Profesor del servicio de endocrinolog\u00eda, Hospital Universitario de Nuevo Le\u00f3n Jos\u00e9 Eleuterio Gonz\u00e1lez, Monterrey, Nuevo Le\u00f3n, M\u00e9xico.\n7 Endocrin\u00f3logo. Profesor investigador, Escuela de Ciencias de la Salud de la Universidad Marista de M\u00e9rida, Yucat\u00e1n, M\u00e9xico.\n8 Endocrin\u00f3logo.\n9 Endocrin\u00f3loga. M\u00e9dico adscrito al departamento de Endocrinolog\u00eda y Metabolismo, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n \u201cSalvador Zubir\u00e1n\u201d\n10 Internista. Presidente m\u00e9dico de la Federaci\u00f3n Mexicana de Diabetes.\n11 Endocrin\u00f3logo. Departamento de endocrinolog\u00eda, Hospital General Regional de Zona n\u00fam. 6, IMSS, Ciudad de M\u00e9xico.\n12 Endocrin\u00f3logo. Profesor e investigador del servicio de endocrinolog\u00eda, Hospital Universitario de Nuevo Le\u00f3n Jos\u00e9 Eleuterio Gonz\u00e1lez, Monterrey, Nuevo Le\u00f3n, M\u00e9xico.\n13 Cirujano General. Secretar\u00eda de Salud.\n14 Internista. Compilador de la Gu\u00eda. Investigador y editor en Paracelsus SA de CV.\n15 M\u00e9dico cirujano. Paracelsus, SA de CV.\nResumen\nLa obesidad es un problema importante a nivel nacional y mundial, que se relaciona con el incremento de casos de hipertensi\u00f3n arterial sist\u00e9mica y diabetes mellitus con el consecuente incremento en la morbilidad y mortalidad y costos para la salud, por lo que se necesitan pol\u00edticas de prevenci\u00f3n de la misma, un diagn\u00f3stico temprano y un tratamiento eficaz y seguro, con los que se reduzcan las posibilidades de reca\u00edda. Recientemente se aprob\u00f3 la lorcaserina para el tratamiento farmacol\u00f3gico de la obesidad. El objetivo de este art\u00edculo es realizar una revisi\u00f3n de la bibliografia cient\u00edfica disponible y actualizada sobre lorcaserina y ser un marco de referencia para la toma de decisiones respecto a la prescripci\u00f3n de este f\u00e1rmaco. Para la elaboraci\u00f3n de la gu\u00eda motivo de esta reuni\u00f3n se cont\u00f3 con la participaci\u00f3n de especialistas en medicina interna, endocrinolog\u00eda, un bibliotecario y un experto en metodolog\u00eda; se realiz\u00f3 una b\u00fasqueda extensa en PubMed y en otros sitios web especializados. Se concluye que la lorcaserina es un f\u00e1rmaco bien tolerado con leves efectos adversos y buen perfil de seguridad a dosis de 10 mg dos veces al d\u00eda, adem\u00e1s, ha mostrado beneficios en el control gluc\u00e9mico en pacientes con diabetes mellitus tipo 2.\nPALABRAS CLAVE: Obesidad; lorcaserina; diabetes mellitus tipo 2; control gluc\u00e9mico.\nAbstract\nObesity is an important problem both nationally and worldwide, this is related to the increase in cases of systemic arterial hypertension and diabetes mellitus with the consequent increase in morbidity and mortality and health costs, which emphasizes the need for health policies for an early diagnosis and effective and safe treatment. Recently, the use of lorcaserin for the pharmacological treatment of obesity was approved. The objective of this article is to review the available and updated scientific literature on lorcaserin and be a reference framework for decision-making regarding the prescription of this drug. For the preparation of this guide specialists in internal medicine, endocrinology, a librarian and an expert in methodology were involved. An extensive search was conducted on PubMed and other specialized websites. It is concluded that lorcaserin is a well tolerated drug with mild adverse effects and a good safety profile at a dose of 10 mg twice a day, it has also presented benefits in glycemic control in patients with type 2 diabetes mellitus.\nKEYWORDS: Obesity; Lorcaserin; Type 2 diabetes; Glycemic control.\nRecibido: 2 de diciembre 2019\nAceptado: 11 de febrero 2020\nCorrespondencia\nEste art\u00edculo debe citarse como: Yamamoto-Cuevas J, Almeda-Vald\u00e9s P, Castro-Mart\u00ednez G, Duarte-Vega M, Gonz\u00e1lez-Gir\u00f3n G, Lavalle-Gonz\u00e1lez FJ, Laviada-Molina HA, Mesa-P\u00e9rez JA, Pravin-Mehta R, S\u00e1nchez-Mijangos JH, Violante-Ortiz RM, Z\u00fa\u00f1iga-Guajardo S, G\u00f3mez-Miranda E, Aldrete-Velasco JA, Camacho-Silva B, Mondrag\u00f3n-Ben\u00edtez O. Lorcaserina: una nueva alternativa para el tratamiento de la obesidad. Med Int M\u00e9x 2022; 38 (1): 121-129.", "language": null, "image": null, "pagetype": null, "links": ["#", "https://medicinainterna.org.mx/5653/", "#", "https://medicinainterna.org.mx/5653/", "https://medicinainterna.org.mx/aviso-de-privacidad/", "https://www.revisionporpares.com/index.php/MIM/user", "/contacto/", "https://medicinainterna.org.mx/busqueda/", "https://medicinainterna.org.mx/tag/ancianos/", "https://medicinainterna.org.mx/tag/artritis-reumatoide/", "https://medicinainterna.org.mx/tag/aterosclerosis/", "https://medicinainterna.org.mx/tag/calidad-de-vida/", "https://medicinainterna.org.mx/tag/choque-septico/", "https://medicinainterna.org.mx/tag/cirrosis-hepatica/", "https://medicinainterna.org.mx/tag/coronavirus/", "https://medicinainterna.org.mx/tag/covid-19/", "https://medicinainterna.org.mx/tag/diabetes/", "https://medicinainterna.org.mx/tag/diabetes-mellitus/", "https://medicinainterna.org.mx/tag/diabetes-mellitus-tipo-2/", "https://medicinainterna.org.mx/tag/diagnostico/", "https://medicinainterna.org.mx/tag/dialisis-peritoneal/", "https://medicinainterna.org.mx/tag/educacion-medica/", "https://medicinainterna.org.mx/tag/embarazo/", "https://medicinainterna.org.mx/tag/enfermedad-renal-cronica/", "https://medicinainterna.org.mx/tag/hemodialisis/", "https://medicinainterna.org.mx/tag/hipertension/", "https://medicinainterna.org.mx/tag/hipertension-arterial/", "https://medicinainterna.org.mx/tag/hiperuricemia/", "https://medicinainterna.org.mx/tag/infarto-agudo-de-miocardio/", "https://medicinainterna.org.mx/tag/insuficiencia-cardiaca/", "https://medicinainterna.org.mx/tag/insuficiencia-renal-aguda/", "https://medicinainterna.org.mx/tag/lesion-renal-aguda/", "https://medicinainterna.org.mx/tag/lupus-eritematoso-sistemico/", "https://medicinainterna.org.mx/tag/medicina-interna/", "https://medicinainterna.org.mx/tag/mexico/", "https://medicinainterna.org.mx/tag/nefropatia-diabetica/", "https://medicinainterna.org.mx/tag/neumonia/", "https://medicinainterna.org.mx/tag/obesidad/", "https://medicinainterna.org.mx/tag/pandemia/", "https://medicinainterna.org.mx/tag/pronostico/", "https://medicinainterna.org.mx/tag/rabdomiolisis/", "https://medicinainterna.org.mx/tag/riesgo-cardiovascular/", "https://medicinainterna.org.mx/tag/sars-cov-2/", "https://medicinainterna.org.mx/tag/sepsis/", "https://medicinainterna.org.mx/tag/sindrome-coronario-agudo/", "https://medicinainterna.org.mx/tag/sindrome-metabolico/", "https://medicinainterna.org.mx/tag/tratamiento/", "https://medicinainterna.org.mx/tag/trombosis/", "https://medicinainterna.org.mx/tag/tuberculosis/", "https://medicinainterna.org.mx/tag/vasculitis/", "https://medicinainterna.org.mx/tag/ventilacion-mecanica/", "https://medicinainterna.org.mx/tag/vih/", "https://medicinainterna.org.mx/tag/acido-urico/", "https://medicinainterna.org.mx/category/popups/alflorex-menarini/", "https://medicinainterna.org.mx/category/popups/alflorez-menarini/", "https://medicinainterna.org.mx/category/articulo-de-opinion/", "https://medicinainterna.org.mx/category/articulo-de-revision/", "https://medicinainterna.org.mx/category/articulos-originales/", "https://medicinainterna.org.mx/category/carta-al-editor/", "https://medicinainterna.org.mx/category/caso-clinico/", "https://medicinainterna.org.mx/category/popups/cicloferon-varicela-liomont/", "https://medicinainterna.org.mx/category/consenso/", "https://medicinainterna.org.mx/category/popups/coriatros-siegfried-rhein/", "https://medicinainterna.org.mx/category/popups/coriatros-siegfried-rhein-sin-ipp/", "https://medicinainterna.org.mx/category/popups/coriatros-siegfried-sin-ipp/", "https://medicinainterna.org.mx/category/popups/cortax/", "https://medicinainterna.org.mx/category/popups/dorixina-flam-siegfried-rhein/", "https://medicinainterna.org.mx/category/editorial/", "https://medicinainterna.org.mx/category/popups/evocs-respitratorias-liomont/", "https://medicinainterna.org.mx/category/popups/expomed/", "https://medicinainterna.org.mx/category/popups/gantena-1-3-kastandi-senosiain/", "https://medicinainterna.org.mx/category/popups/garbican-liomont-sin-ipp/", "https://medicinainterna.org.mx/category/in-memoriam/", "https://medicinainterna.org.mx/category/popups/italdermol-italmex-con-ipp/", "https://medicinainterna.org.mx/category/popups/jarsix-y-nexus-h-cintillos-senosiain/", "https://medicinainterna.org.mx/category/popups/kirruz-italmex-ipp/", "https://medicinainterna.org.mx/category/popups/lactipan-italmex-separador/", "https://medicinainterna.org.mx/category/popups/legalon-meda/", "https://medicinainterna.org.mx/category/popups/lunarium-italmex-con-ipp/", "https://medicinainterna.org.mx/category/popups/lurvimi-ciproflox-dm-cintillos-senosiain/", "https://medicinainterna.org.mx/category/popups/neuroflax-sanfer-con-ipp/", "https://medicinainterna.org.mx/category/popups/nexus-h-cintillo-arfla-senosiain/", "https://medicinainterna.org.mx/category/popups/oksen-tercio-arfla/", "https://medicinainterna.org.mx/category/popups/quadriloid-liomont/", "https://medicinainterna.org.mx/category/popups/quimara-liomont-popups/", "https://medicinainterna.org.mx/category/revision-narrativa/", "https://medicinainterna.org.mx/category/revision-sistematica/", "https://medicinainterna.org.mx/category/rincon-del-internista/", "https://medicinainterna.org.mx/category/popups/rovartal-siegfried-sin-ipp/", "https://medicinainterna.org.mx/category/popups/seltaferon-liomont-sin-ipp/", "https://medicinainterna.org.mx/category/popups/senosiain-biomics-1-3-lurvimi/", "https://medicinainterna.org.mx/category/popups/stadium-sanfer-con-ipp/", "https://medicinainterna.org.mx/category/suplemento/", "https://medicinainterna.org.mx/category/popups/supradol-liomont/", "https://medicinainterna.org.mx/category/popups/thioctacid-meda/", "https://medicinainterna.org.mx/category/popups/ulsicral/", "https://medicinainterna.org.mx/category/popups/viravir-gantena-tercio-senosiain/", "https://medicinainterna.org.mx/category/popups/zinolox-liomont-sin-ipp/", "https://medicinainterna.org.mx/2019/03/", "https://medicinainterna.org.mx/", "https://medicinainterna.org.mx/", "https://medicinainterna.org.mx/nosotros/", "https://medicinainterna.org.mx/nosotros/", "https://medicinainterna.org.mx/aviso-de-privacidad/", "http://#", "https://medicinainterna.org.mx/category/editorial/", "https://medicinainterna.org.mx/category/articulos-originales/", "https://medicinainterna.org.mx/category/caso-clinico/", "https://medicinainterna.org.mx/category/articulo-de-revision/", "https://medicinainterna.org.mx/category/rincon-del-internista/", "https://medicinainterna.org.mx/category/articulo-de-opinion/", "https://medicinainterna.org.mx/category/carta-al-editor/", "https://medicinainterna.org.mx/historico/", "#", "https://medicinainterna.org.mx/autores/", "https://medicinainterna.org.mx/wp-content/uploads/2020/05/Carta-cesion-Med-Int.pdf", "https://medicinainterna.org.mx/ayuda/", "#", "https://medicinainterna.org.mx/", "https://medicinainterna.org.mx/nosotros/", "https://medicinainterna.org.mx/nosotros/", "https://medicinainterna.org.mx/aviso-de-privacidad/", "http://#", "https://medicinainterna.org.mx/category/editorial/", "https://medicinainterna.org.mx/category/articulos-originales/", "https://medicinainterna.org.mx/category/caso-clinico/", "https://medicinainterna.org.mx/category/articulo-de-revision/", "https://medicinainterna.org.mx/category/rincon-del-internista/", "https://medicinainterna.org.mx/category/articulo-de-opinion/", "https://medicinainterna.org.mx/category/carta-al-editor/", "https://medicinainterna.org.mx/historico/", "#", "https://medicinainterna.org.mx/autores/", "https://medicinainterna.org.mx/wp-content/uploads/2020/05/Carta-cesion-Med-Int.pdf", "https://medicinainterna.org.mx/ayuda/", "https://medicinainterna.org.mx/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/#respond", "https://medicinainterna.org.mx/category/revision-narrativa/", "https://medicinainterna.org.mx/descarga/11360/?tmstv=1678261130", "https://doi.org/10.24245/mim.v38i1.3733", null, "mailto:dryamajorge@gmail.com", "https://medicinainterna.org.mx/tag/control-glucemico/", "https://medicinainterna.org.mx/tag/diabetes-mellitus-tipo-2/", "https://medicinainterna.org.mx/tag/lorcaserina/", "https://medicinainterna.org.mx/tag/obesidad/", "https://www.facebook.com/sharer/sharer.php?u=https://medicinainterna.org.mx/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/", "http://twitter.com/share?url=https://medicinainterna.org.mx/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/&text=Lorcaserina%3A+una+nueva+alternativa+para+el+tratamiento+de+la+obesidad", "https://pinterest.com/pin/create/button/?url=https://medicinainterna.org.mx/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/&media=https://medicinainterna.org.mx/wp-includes/images/media/default.png&description=Lorcaserina%3A+una+nueva+alternativa+para+el+tratamiento+de+la+obesidad", "https://plus.google.com/share?url=https://medicinainterna.org.mx/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/", "https://medicinainterna.org.mx/author/sofiaimpacta-science/", "/article/lorcaserina-una-nueva-alternativa-para-el-tratamiento-de-la-obesidad/#respond", null, "https://medicinainterna.org.mx/profile/edit/?a=pwdreset", "https://medicinainterna.org.mx/profile/register/", "https://medicinainterna.org.mx/profile/register/?swcfpc=1", "http://dgb.unam.mx/periodica/html", "http://www.latindex.org", "mailto:articulos@nietoeditores.com.mx", "#", "https://medicinainterna.org.mx/?blackhole=d2a89db32d"]}